Autoimmune Disease News and Research

RSS

Autoimmune Disease is a condition in which the body recognizes its own tissues as foreign and directs an immune response against them.

Lupus patients who adhere to medications have lower risk of type 2 diabetes

Patients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new study from the University of British Columbia.

11 Feb 2020

High bacterial levels in half of lupus skin rashes

A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.

9 Feb 2020

Turning stink into therapy for atherosclerosis

In an amusing but amazing turnaround, it seems the most foul-smelling compound on earth, called putrescine, could help relieve chronic inflammation, most importantly in the arterial thickening called atherosclerosis. This discovery is reported in the journal Cell Metabolism in January 2020.

30 Jan 2020

AARDA announces new partnership with AutoimmuneMom

The American Autoimmune Related Disease Association (AARDA) is thrilled to announce our new partnership with AutoimmuneMom.

30 Jan 2020

FDA approves new drug that could aid MS diagnoses for clinical trials

A new drug that could make it easier for doctors to diagnose multiple sclerosis in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration.

27 Jan 2020

Lymphopenia may hint a higher risk of future illness, death

Lymphopenia, which indicates lower levels of lymphocytes in the blood, has been tied to a higher risk of future illness and death, a new study found.

13 Jan 2020

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Research adds definitive evidence about how the body's earliest immune cells are formed

One day the advance could lead to a patient's own skin cells being used to produce new cells for cancer immunotherapy or to test autoimmune disease interventions.

8 Jan 2020

Clinical trial tests experimental stem cell treatment against best available drugs for MS

A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis.

7 Jan 2020

Bile acids could also play a role in immunity and inflammation

Could bile acids--the fat-dissolving juices churned out by the liver and gallbladder--also play a role in immunity and inflammation?

3 Jan 2020

New mechanism that impairs Treg differentiation and stability in type 1 diabetes discovered

Regulatory T cells (Tregs) prevent excessive immune reactions in healthy people. In the development of autoimmune type 1 diabetes, this protection is not sufficiently effective.

19 Dec 2019

Scientists explore role of IgG4 Abs in IgG4-related disease

Autoimmune diseases are a medical conundrum. In people with these conditions, the immune system of the body, the designated defense system, starts attacking the cells or organs of its own body, mistaking the self-cells for invading disease-causing cells. Often, the cause for this spontaneous dysfunction is not clear, and hence, treatment of these diseases presents a major and ongoing challenge.

18 Dec 2019

New standards needed for improving the design of clinical trials for MS patients

How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was investigated and corresponding recommendations were developed by a working group of the Drug Commission of the German Medical Association, the Charité University Hospital Berlin, and the Institute for Quality and Efficiency in Health Care.

17 Dec 2019

Study finds new drivers of destructive inflammation

Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases.

17 Dec 2019

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

The results of a study conducted in Brazil suggest that the sympathetic nervous system - the part of the autonomous nervous system that controls responses to danger or stress - can modulate the action of defense cells in patients with autoimmune diseases.

16 Dec 2019

Wayne State's College of Engineering receives $1.7 million to develop novel insulin delivery system

Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin -- a hormone that regulates blood sugar -- or the body cannot effectively use the insulin it produces. According to the Diabetes Research Institute Foundation, the disease is increasing at an alarming rate in the United States, with an estimated 30.3 million people currently with diabetes.

12 Dec 2019

JDRF announces more than $8 million in new funds to accelerate cutting-edge T1D research

JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced that it has committed 23 training grants, totaling more than $8 million in new funds to accelerate T1D research and the next generation of T1D experts, representing 9 states, as well as Australia, France, Canada, Germany, Denmark, Switzerland and the United Kingdom, in partnership with 20 institutions.

12 Dec 2019

Autoimmune Disease News and Research

Further Reading

Lupus patients who adhere to medications have lower risk of type 2 diabetes

High bacterial levels in half of lupus skin rashes

Turning stink into therapy for atherosclerosis

AARDA announces new partnership with AutoimmuneMom

FDA approves new drug that could aid MS diagnoses for clinical trials

Lymphopenia may hint a higher risk of future illness, death

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Research adds definitive evidence about how the body's earliest immune cells are formed

Clinical trial tests experimental stem cell treatment against best available drugs for MS

Bile acids could also play a role in immunity and inflammation

New mechanism that impairs Treg differentiation and stability in type 1 diabetes discovered

Scientists explore role of IgG4 Abs in IgG4-related disease

New standards needed for improving the design of clinical trials for MS patients

Study finds new drivers of destructive inflammation

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

Wayne State's College of Engineering receives $1.7 million to develop novel insulin delivery system

JDRF announces more than $8 million in new funds to accelerate cutting-edge T1D research

Researchers aim to improve oral delivery of insulin for diabetes patients

Yale scientists flip the script on novel cancer therapy to find new insights into lupus

UCLA scientists discover reason for higher rates of autoimmune disease in women than men

Understanding the DNA Damage Response in Innate Immunity eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News